article

1. Palbociclib in adults aged 70 years and older with advanced breast cancer: A phase 2 multicenter trial (Alliance A171601)..  Journal of geriatric oncology.  15:-. 2024
2. Functional decline in older breast cancer survivors treated with and without chemotherapy and non-cancer controls: results from the Hurria Older PatiEnts (HOPE) prospective study..  Journal of cancer survivorship : research and practice.  18:1131-1143. 2024
3. Outcome prioritization and preferences among older adults with cancer starting chemotherapy in a randomized clinical trial..  Cancer.  130:3000-3010. 2024
4. Effect of chemotherapy on hippocampal volume and shape in older long-term breast cancer survivors..  Frontiers in aging neuroscience.  -. 2024
5. Randomized placebo-controlled, double-blind clinical trial of nanoemulsion curcumin in women with aromatase inhibitor-induced arthropathy: an Alliance/NCORP pilot trial..  Breast cancer research and treatment.  205:61-73. 2024
6. Brain white matter microstructural changes in chemotherapy-treated older long-term breast cancer survivors..  Cancer medicine.  13:-. 2023
7. Falls prechemotherapy and toxicity-related hospitalization during adjuvant chemotherapy for breast cancer in older women: Results from the prospective multicenter HOPE trial..  Cancer.  130:936-946. 2023
8. Clonal hematopoiesis in older patients with breast cancer receiving chemotherapy..  Journal of the National Cancer Institute.  115:981-988. 2023
9. The Aging-Cancer Cycle: Mechanisms and Opportunities for Intervention..  The journals of gerontology. Series A, Biological sciences and medical sciences.  78:1234-1238. 2023
10. Predicting Hyperglycemia Among Patients Receiving Alpelisib Plus Fulvestrant for Metastatic Breast Cancer..  The oncologist.  28:e488-e492. 2023
11. HER2-targeted antibody-drug conjugates for breast cancer: ancestry and dose adjustment for thrombocytopenia..  Breast cancer (Tokyo, Japan).  30:796-801. 2023
12. Predicting All-Cause Mortality in Women With and Without Breast Cancer Using the Schonberg Index: A Women's Health Initiative Study..  Journal of the National Comprehensive Cancer Network : JNCCN.  21:636-644.e13. 2023
13. Toxicity Risk Score and Clinical Decline After Adjuvant Chemotherapy in Older Breast Cancer Survivors..  Journal of the National Cancer Institute.  115:578-585. 2023
14. Feasibility of implementing a supervised telehealth exercise intervention in frail survivors of hematopoietic cell transplantation: a pilot randomized trial..  BMC cancer.  23:-. 2023
15. Facilitators and Barriers to Older Adult Participation in Cancer Trials: A Qualitative Study Exploring Patient-Caregiver Dyad Congruence..  JCO oncology practice.  19:484-492. 2023
16. Altered gyrification in chemotherapy-treated older long-term breast cancer survivors..  Research square.  2023
17. Hyperglycemia and Glycemic Variability Associated with Glucocorticoids in Women without Pre-Existing Diabetes Undergoing Neoadjuvant or Adjuvant Taxane Chemotherapy for Early-Stage Breast Cancer..  Journal of clinical medicine.  12. 2023
18. The role of self-perceived age in older adults considering adjuvant chemotherapy..  Journal of geriatric oncology.  14:-. 2023
19. Infrastructure to Support Accrual of Older Adults to National Cancer Institute Clinical Trials..  Journal of the National Cancer Institute. Monographs.  2022:151-158. 2022
20. Trial Design Considerations to Increase Older Adult Accrual to National Cancer Institute Clinical Trials..  Journal of the National Cancer Institute. Monographs.  2022:135-141. 2022
21. Low-Intensity Adjuvant Chemotherapy for Breast Cancer in Older Women: Results From the Prospective Multicenter HOPE Trial..  Journal of clinical oncology : official journal of the American Society of Clinical Oncology.  41:316-326. 2022
22. Cortical thinning in chemotherapy-treated older long-term breast cancer survivors..  Brain imaging and behavior.  17:66-76. 2022
23. Clinical Trial Enrollment, Ineligibility, and Reasons for Decline in Older vs Younger Patients With Cancer in the National Cancer Institute Community Oncology Research Program..  JAMA network open.  5:-. 2022
24. 'ADVANCE' (a pilot trial) ADjuVANt chemotherapy in the elderly: Developing and evaluating lower-toxicity chemotherapy options for older patients with breast cancer..  Journal of geriatric oncology.  14:-. 2022
25. Signal Variability and Cognitive Function in Older Long-Term Survivors of Breast Cancer with Exposure to Chemotherapy: A Prospective Longitudinal Resting-State fMRI Study..  Brain sciences.  12. 2022
26. Inflammation and Clinical Decline After Adjuvant Chemotherapy in Older Adults With Breast Cancer: Results From the Hurria Older Patients Prospective Study..  Journal of clinical oncology : official journal of the American Society of Clinical Oncology.  41:307-315. 2022
27. Resilience in older adults with cancer: A scoping literature review..  Journal of geriatric oncology.  14:-. 2022
28. Feasibility and Satisfaction of Using NET VITALS Self-assessment Tool Among Patients With Neuroendocrine Tumors..  Pancreas.  51:319-324. 2022
29. Interpretation of the Efficacy of Multidisciplinary Geriatric Assessment Intervention on Chemotherapy-Related Toxic Effects in Older Adults With Cancer-Reply..  JAMA oncology.  8:-. 2022
30. Multimodality Treatment with Radiotherapy and Immunotherapy in Older Adults: Rationale, Evolving Data, and Current Recommendations..  Seminars in radiation oncology.  32:142-154. 2022
31. Representation and Outcomes of Older Adults in Practice-Changing Oncology Trials in the Era of Novel Therapies: A Guideline Appraisal..  Journal of the National Comprehensive Cancer Network : JNCCN.  20:37-44. 2022
32. Geriatric Assessment-Driven Intervention (GAIN) on Chemotherapy-Related Toxic Effects in Older Adults With Cancer: A Randomized Clinical Trial..  JAMA oncology.  7:-. 2021
33. NCCN Guidelines® Insights: Older Adult Oncology, Version 1.2021..  Journal of the National Comprehensive Cancer Network : JNCCN.  19:1006-1019. 2021
34. Accelerated aging in older cancer survivors..  Journal of the American Geriatrics Society.  69:3077-3080. 2021
35. Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer..  European journal of cancer (Oxford, England : 1990).  11-20. 2021
36. ELF5.  Cancer prevention research (Philadelphia, Pa.).  14:779-794. 2021
37. Improving Care for Spanish-Speaking Older Adults with Breast Cancer: Feasibility, Reliability, and Validity of a Self-Administered Spanish Language Geriatric Assessment..  Cancers.  13. 2021
38. Measuring Biologic Resilience in Older Cancer Survivors..  Journal of clinical oncology : official journal of the American Society of Clinical Oncology.  39:2079-2089. 2021
39. Effect of chemotherapy on default mode network connectivity in older women with breast cancer..  Brain imaging and behavior.  16:43-53. 2021
40. Characteristics Associated With Functional Changes During Systemic Cancer Treatments: A Systematic Review Focused on Older Adults..  Journal of the National Comprehensive Cancer Network : JNCCN.  19:1055-1062. 2021
41. Weathering the Storm: Managing Older Adults With Breast Cancer Amid COVID-19 and Beyond..  Journal of the National Cancer Institute.  113:355-359. 2021
42. Electronic Geriatric Assessment: Is It Feasible in a Multi-Institutional Study That Included a Notable Proportion of Older African American Patients? (Alliance A171603)..  JCO clinical cancer informatics.  435-441. 2021
43. Individualizing Surveillance Mammography for Older Patients After Treatment for Early-Stage Breast Cancer: Multidisciplinary Expert Panel and International Society of Geriatric Oncology Consensus Statement..  JAMA oncology.  7:609-615. 2021
44. Phase II study of neratinib in older adults with HER2 amplified or HER2/3 mutated metastatic breast cancer..  Journal of geriatric oncology.  12:752-758. 2021
45. Perspectives on Geriatric Oncology Research Presented at the 2020 San Antonio Breast Cancer Symposium..  Journal of geriatric oncology.  12:483-488. 2021
46. Development and Validation of a Risk Tool for Predicting Severe Toxicity in Older Adults Receiving Chemotherapy for Early-Stage Breast Cancer..  Journal of clinical oncology : official journal of the American Society of Clinical Oncology.  39:608-618. 2021
47. Integrating Academic and Community Cancer Care and Research through Multidisciplinary Oncology Pathways for Value-Based Care: A Review and the City of Hope Experience..  Journal of clinical medicine.  10. 2021
48. Breast cancer associated pathogenic variants among women 61 years and older with triple negative breast cancer..  Journal of geriatric oncology.  12:749-751. 2020
49. Investigator Use of Social Media for Recruitment of Patients for Cancer Clinical Trials..  JAMA network open.  3:-. 2020
50. A Phase II Clinical Trial of Pembrolizumab and Enobosarm in Patients with Androgen Receptor-Positive Metastatic Triple-Negative Breast Cancer..  The oncologist.  26:99-e217. 2020
51. Corrigendum to 'Patterns of care and treatment outcomes in patients age 80 or older with non-metastatic pancreatic cancer' [Journal of Geriatric Oncology 11 (4) (2020) 652-659]..  Journal of geriatric oncology.  12:-. 2020
52. Older adult participation in cancer clinical trials: A systematic review of barriers and interventions..  CA: a cancer journal for clinicians.  71:78-92. 2020
53. Growth of the Social #RadOnc Network on Twitter..  Practical radiation oncology.  11:e263-e266. 2020
54. The Effects of Time to Treatment Initiation for Patients With Non-small-cell Lung Cancer in the United States..  Clinical lung cancer.  22:e84-e97. 2020
55. Use of HER2-Directed Therapy in Metastatic Breast Cancer and How Community Physicians Collaborate to Improve Care..  Journal of clinical medicine.  9. 2020
56. Implementing Lung Cancer Screening and Prevention in Academic Centers, Affiliated Network Offices and Collaborating Care Sites..  Journal of clinical medicine.  9. 2020
57. Strategies to Improve Participation of Older Adults in Cancer Research..  Journal of clinical medicine.  9. 2020
58. The Evolving Complexity of Treating Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer: Special Considerations in Older Breast Cancer Patients-Part I: Early-Stage Disease..  Drugs & aging.  37:331-348. 2020
59. The Evolving Complexity of Treating Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer: Special Considerations in Older Breast Cancer Patients-Part II: Metastatic Disease..  Drugs & aging.  37:349-358. 2020
60. Online Health Information-Seeking Among Older Women With Chronic Illness: Analysis of the Women's Health Initiative..  Journal of medical Internet research.  22:-. 2020
61. Barriers to Participation in Therapeutic Clinical Trials as Perceived by Community Oncologists..  JCO oncology practice.  16:e849-e858. 2020
62. Patterns of care and treatment outcomes in patients age 80 or older with non-metastatic pancreatic cancer..  Journal of geriatric oncology.  11:652-659. 2019
63. Decreasing incidence of upper age restriction enrollment criteria among cancer clinical trials..  Journal of geriatric oncology.  11:451-454. 2019
64. Effects of chemotherapy on aging white matter microstructure: A longitudinal diffusion tensor imaging study..  Journal of geriatric oncology.  11:290-296. 2019
65. Older breast cancer survivors may harbor hereditary cancer predisposition pathogenic variants and are at risk for clonal hematopoiesis..  Journal of geriatric oncology.  11:316-319. 2019
66. Physician Perceptions of the Use of Social Media for Recruitment of Patients in Cancer Clinical Trials..  JAMA network open.  2:-. 2019
67. The role of comprehensive geriatric assessment in radiation oncology..  Journal of geriatric oncology.  11:194-196. 2019
68. Arti Hurria and the progress in integrating the geriatric assessment into oncology: Young International Society of Geriatric Oncology review paper..  Journal of geriatric oncology.  11:203-211. 2019
69. Cores for geriatric oncology infrastructure in the Cancer and Aging Research Group: Biostatistics, epidemiology, and research design (the analytics core)..  Journal of geriatric oncology.  11:355-358. 2019
70. Telehealth in geriatric oncology: A novel approach to deliver multidisciplinary care for older adults with cancer..  Journal of geriatric oncology.  11:197-199. 2019
71. Arti Hurria, M.D.: A tribute to her shining legacy in the Alliance for Clinical Trials in Oncology..  Journal of geriatric oncology.  11:179-183. 2019
72. Breast cancer and aging: Standing on the shoulders of a giant..  Journal of geriatric oncology.  11:212-216. 2019
73. Mentoring pearls of wisdom: Lessons learned by mentees of Arti Hurria, MD..  Journal of geriatric oncology.  11:335-337. 2019
74. Catching Arti's kisses..  Journal of geriatric oncology.  11:147-148. 2019
75. Intrinsic brain activity changes associated with adjuvant chemotherapy in older women with breast cancer: a pilot longitudinal study..  Breast cancer research and treatment.  176:181-189. 2019
76. Older-Patient-Specific Cancer Trials: A Pooled Analysis of 2,277 Patients (A151715)..  The oncologist.  24:e284-e291. 2019
77. Examining Public Communication About Kidney Cancer on Twitter..  JCO clinical cancer informatics.  1-6. 2019
78. Shifting paradigms: whole brain radiation therapy versus stereotactic radiosurgery for brain metastases..  CNS oncology.  8:-. 2019
79. Perspectives on geriatric oncology research presented at the 2018 San Antonio Breast Cancer Symposium..  Journal of geriatric oncology.  10:192-195. 2019
80. Incorporating Digital Tools to Improve Clinical Trial Infrastructure: A White Paper From the Digital Engagement Committee of SWOG..  JCO clinical cancer informatics.  1-8. 2018
81. Use of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors in older patients with ER-positive HER2-negative breast cancer: Young International Society of Geriatric Oncology review paper..  Therapeutic advances in medical oncology.  -. 2018
82. Simple Frameworks for Daily Work: Innovative Strategies to Coach Residents Struggling With Time Management, Organization, and Efficiency..  Journal of graduate medical education.  10:325-330. 2018
83. Integrating Social Media in Modern Oncology Practice and Research..  American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.  894-902. 2018
84. Cancer in the older adult: Implications for therapy and future research..  Cancer.  124:1108-1110. 2018
85. Risks and benefits of Twitter use by hematologists/oncologists in the era of digital medicine..  Seminars in hematology.  54:198-204. 2017
86. Effect of a Price Transparency Intervention in the Electronic Health Record on Clinician Ordering of Inpatient Laboratory Tests: The PRICE Randomized Clinical Trial..  JAMA internal medicine.  177:939-945. 2017
87. The emerging role of professional social media use in oncology..  Future oncology (London, England).  13:1281-1285. 2017
88. Residents' self-report on why they order perceived unnecessary inpatient laboratory tests..  Journal of hospital medicine.  11:869-872. 2016
89. Cancer Communication in the Social Media Age..  JAMA oncology.  2:822-3. 2016
90. Social media in cancer care: highlights, challenges & opportunities..  Future oncology (London, England).  12:1549-52. 2016
91. Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study..  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.  11:1601-8.e1-4. 2013
92. Thymic neuroendocrine tumor presenting with the ectopic ACTH syndrome..  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.  8:e57-8. 2013